# A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer

> **NCT05235516** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Akeso** · enrollment: 636 (estimated)

## Conditions studied

- Locally Advanced Cervical Carcinoma

## Interventions

- **DRUG:** AK104
- **RADIATION:** EBRT
- **RADIATION:** BT
- **DRUG:** cisplatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05235516
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2026-05
- **Final completion:** 2029-05
- **Target enrollment:** 636 (ESTIMATED)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05235516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05235516, "A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05235516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*